To hear about similar clinical trials, please enter your email below
Trial Title:
A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients
NCT ID:
NCT06127121
Condition:
Cancer
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Behavioral
Intervention name:
Digital Art Activity
Description:
- complete a symptom questionnaire
- complete another activity such as listening to meditative music for 10 minutes
- fill out the symptom questionnaire and engage in the digital art activity again
Arm group label:
Digital Art Activity
Summary:
To look at how a digital art activity may help cancer patients improve their ability to
express their distress, symptoms, and lived experience.
Detailed description:
Primary objective:
- To evaluate how engaging in a digital art activity might potentially cause changes
in symptom reporting, based on pre/post self-reporting on the Edmonton Symptom
Assessment System (ESAS) at time T3.
Secondary objectives:
- To evaluate the changes in symptom reporting, based on pre/post self-reporting on
ESAS at different times of the study (T1, T2).
- To evaluate how a specific creative art making activity (T3), compared to an active
control condition (T2; music listening) may or may not impact reporting ESAS.
- To monitor potential changes in distress disclosure, based on the self-report
scoring on the Distress Disclosure Index score at T0, T2 and T3.
Criteria for eligibility:
Study pop:
M D Anderson Cancer Center
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
1. Age equal or greater than 18 years
2. Patients who are admitted in the hospital and have received a cancer diagnosis
within six months to one year of the study.
3. Suffering from colorectal cancer, breast cancer, pancreatic cancer or lung cancer
and receiving active treatment for their cancer.
4. Voluntary written consent.
5. Fluent in English or Spanish.
Exclusion Criteria:
1. Not being able to use a digital tablet
2. Being speech impaired or vision impaired
3. Patients who are cognitively impaired and unable to read or consent for the study
4. Pregnant women
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
MD Anderson Cancer Center
Address:
City:
Houston
Zip:
77030
Country:
United States
Status:
Recruiting
Contact:
Last name:
Carlos Roldan, MD
Phone:
713-563-7402
Email:
croldan@mdanderson.org
Investigator:
Last name:
Carlos Roldan, MD
Email:
Principal Investigator
Start date:
November 2, 2023
Completion date:
August 31, 2025
Lead sponsor:
Agency:
M.D. Anderson Cancer Center
Agency class:
Other
Source:
M.D. Anderson Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06127121
http://www.mdanderson.org
